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Abstract (230 words)
Introduction: Approximately 30% of women treated for breast cancer will develop lymphedema, yet early
identification can prevent this occurrence. It is important to accurately and efficiently measure
limb volume to identify pre-clinical lymphedema. Three-dimensional (3D) imaging is emerging
as a potential method to meet the need for accuracy and efficiency. The purpose of this review
was to evaluate the psychometrics of 3D imaging to measure limb volume.
Methods: A systematic search of 4 databases was conducted for articles using 3D imaging to measure
limb volume. Articles were included that compared 3D imaging to water displacement using
human subjects from 2000 to present. Data related to relevant psychometrics (validity, reliability,
responsiveness) and patient populations were extracted from each article and analyzed. Risk of
bias in study design was also assessed for each article.
Results: The initial search of publications included 141 articles, in which 27 articles were selected based
on the title and abstract. Only 13 articles were selected after full text review. Evidence from a
preponderance of high quality studies demonstrates that 3D imaging is valid and reliable.
Discussion: 3D scanning can provide an accurate and efficient alternative means of measuring limb
volume in breast cancer related lymphedema when compared to the reference standard of water
displacement. Limitations to immediate clinical adoption include lack of information related to
diagnostic accuracy and responsiveness, as well as a uniform definition of lymphedema.
Keywords: lymphedema, breast neoplasms, infrared scanning, psychometrics, measurement
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Introduction
Lymphedema is a chronic condition that can affect 30-60% of women treated for breast cancer,
impacting up to 2 million women in the United States.[1, 2, 3] Breast cancer-related lymphedema
(BCRL) is associated with decreased functional independence, increased treatment costs on
average of approximately $1000/year, and decreased overall health-related quality of life when
compared to patients with breast cancer without lymphedema.[3, 4] Risk factors for BCRL
include a higher body mass index and more extensive cancer treatments such as axillary node
dissection and axillary radiation, but no clear pattern of who will develop lymphedema exists.[5]
Swelling of the upper extremities is the cardinal sign of lymphedema and frequently is identified
by healthcare clinicians through observation.[6] However, by the time swelling is visible, the
lymphedema has often progressed to stage 2, and is not reversible. Evidence from a large scale
study demonstrates that preclinical lymphedema, that which occurs with a >3% limb volume
difference from preoperative values and is not visible clinically, was reversible with the use of
compression.[7] It is therefore critical for early identification of increased limb volume before the
development of visual swelling, and irreversible lymphedema, occurs.
Limb volume can be measured in multiple ways including water displacement (WD),
circumferential measurement (CM), bioelectrical impedance spectroscopy (BIS), and infrared
scanning. Current methods of measuring limb volume present challenges in clinical use.
Concerns over infection control and efficiency plague the use of water displacement.[8, 9] Limb
girth or volumetric calculations using circumferential measures of arm with a flexible tape at set
intervals are considered both valid and reliable, however this method of measurement also
suffers from time constraints.[9] Additionally, using circumferential measures to calculate
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volume using a truncated cone formula often overestimates limb volume because the contours of
the arm do not match that of a truncated cone or frustum.[10, 11] Bioelectrical impedance does
show promise for early diagnosis of limb volume changes, but suffers accuracy in later stage
lymphedema because the tissues become more fibrotic and less excess fluid is present.[12]
Perometry uses infrared scanning to create a three-dimensional (3D) model and is specifically
designed to measure limb volume. It allows for fast, accurate, and hygienic measurements of arm
volumes and facilitates routine monitoring of arm volumes.[13, 14] The hefty price tag of a
Perometer however, relegates its primary use to research labs or larger academic medical centers.
An inexpensive, efficient, valid and reliable method to measure limb volume is needed for early
identification of volume increases among women treated for breast cancer.
While measuring limb girth to diagnose lymphedema is relatively common, using the
multiple methods, there are nearly as many different diagnostic criteria that confound a
consistent definition of what lymphedema is. The International Society of Lymphology
consensus document stages lymphedema from Stage 0 – subclinical with no visible swelling
through Stage 1 – reversible swelling, Stage 2 – consistent swelling with pitting, to Stage 3 –
persistent swelling with skin changes.[15] This guideline does not define a clear objective
number associated with the diagnosis of lymphedema at any stage. Other common diagnostic
criteria cut points for lymphedema are: a 2 centimeter (cm) increase in limb girth, a 200-mL or
more increase in limb volume, or a 5% or greater limb volume change.[5, 6] Pre-clinical
lymphedema, defined as a change in limb volume of 3-5%, would align with Stage 0-1, while
volume of 5% or greater is considered lymphedema.[7] The Academy of Oncologic Physical
Therapy Clinical Practice Guideline on the Diagnosis of Upper Quadrant Lymphedema
Secondary to Cancer makes specific recommendations for the diagnosis of lymphedema that
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would include either absolute volume change or percentage change.[12] A percentage change
more accurately reflects relative change; a 2 cm increase may be visible in smaller arms and
practically undetectable in larger arms; furthermore 2 cm in a small arm may be significantly
greater percentage change than in a larger arm.
Emerging technologies can address the limitations that water displacement and
circumferential measures pose in a clinic to measure limb volume. Valid, reliable, and efficient
methods may result in earlier identification of BCRL, track volume changes of the arm, and be
more readily available in clinics. Portable 3D scanners may meet this need. Similar to perometry
in image generation, which has established validity and reliability, portable 3D scanning is
significantly less expensive and likely within the reach of clinics to obtain. More time efficient
than circumferential measures, more cost efficient and smaller than perometers, portable handheld 3D scanners that prove to be valid and reliable may facilitate widespread clinical use,
increasing early identification of lymphedema. In addition, the ease of use and decreased time
associated with these newer methods compared to water displacement could lead to better and
more effective monitoring of limb volume in patients who are at risk for developing
lymphedema. This would allow for earlier intervention, which can significantly reduce the effect
of lymphedema on functional activities as well as a decrease in treatment costs.[3] Given the
need for more efficient, yet cost-effective and easy to use valid and reliable tools to measure
limb volume, the purpose of this review was to evaluate the psychometric properties of 3D
imaging for measuring limb volume in identifying lymphedema.

Methods
Research Question

5

The research question that shaped the search strategy was formulated using the PICO
framework. The preferred population of interest focused on those with breast cancerrelated lymphedema, however as 3D imaging is a developing technology, any study
examining limb volume in adults was of interest. The only exception to this included limb
volume of residual limbs in a population of individuals with amputations as the authors felt
a complete limb was a better reference standard for the population of interest. The
intervention, assessment in this question, was 3D imaging. The comparison of primary
interest was water displacement methods of volume measurement, however studies which
reported other comparison measure in addition to water displacement were still included.
Finally, the outcome of interest was measurement of limb volume.
Search Strategy
A comprehensive literature search with the assistance of a librarian was conducted in October
2019 using bibliographic databases including PubMed, CINAHL, Cochrane Library and Google
Scholar. The search initially was intentionally focused on breast cancer-related
lymphedema and 3D imaging in a broad sense, and included MeSH terms: "Breast Cancer
Lymphedema/diagnosis" OR "Breast Cancer Lymphedema/diagnostic imaging" OR
"Lymphatic Vessels/diagnostic imaging" OR "Lymphedema/diagnosis" OR
"Lymphedema/diagnostic imaging" AND "3D imaging" AND "adult." Given the small
number of overall articles in the initial search, the search was expanded to “3D imaging”
AND “lymphedema” to ensure all possible studies were included. Additional key words
included “limb volume,” “perometry,” and “water displacement” with and “lymphedema.”
Perometry was a specific search as it is a method of 3D imaging using infrared scanners to
measure limb volume and studies investigating it did not initially appear in the literature search.
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Reference lists of included articles were reviewed for additional studies. Duplicate studies were
removed based on final search lists using a reference management software.
Selection Criteria
Four reviewers (N.B., M.W., M.V., R.K.) executed an independent literature search and
reviewed titles and abstracts of articles from individual searches. Only peer reviewed, full-text
articles that focused on evaluating the psychometric properties of 3D imaging to measure limb
volume were included. Based on evidence that circumferential measures using a truncated cone
overestimate limb volume, and that water displacement is considered the gold standard reference
standard, only articles that included water displacement for comparison were selected.[10, 11]
Inclusion dates were January 2000 to October 2019. Studies were excluded if the reference
standard against which the 3D systems were compared did not include water displacement, were
editorials or commentaries, or were not available in English. All studies were initially screened
based on title and abstract, followed by full-text review of potential articles.
Data Extraction
Three general categories of 3D scanning of the limb are presented in the literature. Each study
was categorized into one of these methods: Multi-camera Systems, Stationary Systems, or
Portable Systems. The following data were extracted from each study: population, number of
subjects, reference standard(s) used, study quality, and relevant psychometric properties. These
psychometric properties included reliability, validity, accuracy and sensitivity to change, and
clinical utility. Criterion-related (concurrent and predictive) and construct (convergent and
discriminant) validity values were reported when available, as well as measures assessing
accuracy and responsiveness to change such as minimal detectable change (MDC) and minimal
clinically important difference (MCID).
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Quality Assessment
After inclusion, articles were assessed for bias. The Scottish Intercollegiate Guidelines Network
(SIGN) Methodology Checklist (Supplemental Online Material - Appendix) was used to assess
bias of each study.[16, 17] The SIGN is based on the QUADAS2 (Bristol University) bias
assessment, and includes 4 domains covering patient selection, index test methodology, reference
standard choice and methodology, and flow and timing of the study.[18] Each domain is further
divided into risk of bias and applicability to question investigated. The responses from each box
are combined to assess the overall methodological quality of the study as “high”, “acceptable”,
or “low.” Each article was reviewed for bias using the SIGN Methodology Checklist
independently by two of the four authors. In the case of differing assessment, discussion
took place until consensus on bias was reached.
Data Analysis
For the purpose of this review, the following criteria were applied to determine the strength of
the psychometric properties: excellent reliability = >0.90; good reliability = 0.76-0.89; moderate
reliability = 0.50-0.75; and poor reliability <0.50.[19] The quality assessment combined with the
strength of the psychometric properties were used to determine an overall strength of the
evidence.

Results
The initial search for publications resulted in 130 articles; with an additional manual
bibliographic searching resulting in an additional 21 potential articles. With duplicates
removed, 127 underwent title and abstract screening; 100 articles were excluded resulting
in selection of 27 articles for full text review. After completion of full text review, 13 total
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articles fitting the inclusion criteria were selected. While multiple other studies examined the
psychometric properties of 3D scanners, many used circumferential measurements as the
reference standard, and were therefore excluded from this review. Additionally, studies
examining 3D volume measurements of residual limbs in populations of those with amputations
were excluded, as these limbs are different than full limbs of adults with lymphedema. See
Figure 1 for the PRISMA diagram detailing study selection.[20] Table 1 identifies clinical
feasibility of each measurement method including cost, portability, time to complete, and ease of
calculation.
Types of Scanners
Table 2 provides details of included studies, by category. Study population, participant type and
number, relevant psychometrics, and study quality are identified within each category.
Multi-camera Systems. Five studies reported on 3D scanning using multiple cameras: one study
compared a fifteen camera system to water displacement,[21] a second compared a three-camera
system to circumferential measures, water displacement, and ultrasound,[8] and three other
studies examined the Vectra 3D 6-camera system.[22, 23, 24] All but one study included
participants with BCRL; the remaining study examined healthy adults. All of the studies in this
category were graded high quality using the SIGN Methodology Checklist.
Stationary Systems. Three studies reported on 3D scanning using stationary systems. Two
studies validated the Perometer against water displacement measures.[10, 25] One other study
examined a self-positioning laser scanner attached to a computer in comparison to WD
measurements.[26] All studies compared healthy adult controls to individuals with lymphedema;
two studies included women with BCRL and the third included individuals with primary or
secondary lymphedema of the lower extremity. All studies were graded acceptable[10, 25, 26]
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as they used case-control methods. While this is often the study design necessary to determine
discriminant validity, case-control studies tend to exaggerate diagnostic accuracy.[17]
Portable Systems. Five studies reported on 3D scanning using portable systems: one study
compared a digital laser scanner camera to circumferential and water displacement methods,[27]
one study compared a structure made with aluminium with two visible LED light sources, a
Kinect sensor (Microsoft Corporation, Redmond, WA), and two electronic CMOS
(complementary metal-oxide semiconductor) cameras to WD,[28] another used infrared depth
scanners with Kinect sensors,[29], two other studies used a portable, infrared 3D imaging
system.[30, 31] Four of the five studies included only healthy adults while the remaining study
examined adults with filarial lower extremity lymphedema. Four of the five studies using a
portable system were ranked as high quality; the other was acceptable.
Reliability
Multi-camera Systems. Reliability of the multi-camera systems was excellent, with correlation
values exceeding 0.90 for both intra- and inter-rater reliability. In examining Bland-Altman
plots of repeated 3D measures, high agreement was noted. Using paired-samples t-tests,
differences were not significant (p>0.05). Overall, the ability of multi-camera systems to
provide reliable measures of limb volumes is excellent.
Stationary Systems. Of the three studies reviewed that used stationary 3D imaging systems, two
reported a reliability measures for 3D imaging and WD and while the final study also included
the reliability of CM in addition to 3D imaging and WD. Both intra- and inter-rater reliability
correlation coefficients exceeded 0.90 for 3D imaging in all studies. This was similar in the
single study using concordance correlations, with values >0.90 for both intra- and inter-rater
reliability.
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Portable Systems. The reliability of portable systems was evaluated either by the Pearson’s or
intraclass correlation coefficient, Bland-Altman plots for limits of agreement, or by coefficients
of variation. All methods resulted in good to excellent reproducibility, with reported standard
error of the measure (SEM), except for a single study that found a larger variance in the
SEM.[29]
Validity and Accuracy
Concurrent validity was examined in all studies with a consistent reference standard (WD) used
in each. No study reported on predictive, convergent, or discriminant validity. The BlandAltman plots of accuracy generally showed good agreement between 3D imaging and WD,
however, one study did note decreased agreement with increased limb volume.
Multi-camera System. All multi-camera systems examined demonstrated excellent concurrent
validity in comparison to water displacement methods, with correlation values exceeding 0.98.
Stationary Systems. Using concordance statistics, the stationary systems demonstrated high
levels of concordance in excess of 0.90. Only one study examined diagnostic accuracy in this
category of scanners, and the results indicated that the Perometer values were less than CM and
greater than WD.
Portable Systems. These systems demonstrated excellent criterion-related validity in comparison
to water displacement with correlation values exceeding 0.98. Further validation with
circumferential measures as with skin thickness ultrasound was also excellent. Two studies
examined diagnostic accuracy. Bland-Altman analyses showed no difference with WD and no
proportional errors, while the other noted that 3D imaging underestimated volume as limb size
increased.
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Discussion
The primary purpose of this review was to investigate the psychometric properties of 3D analysis
to measure limb volume. While the included articles evaluated multi-camera, stationary, and
portable systems, all systems demonstrated acceptable to excellent psychometric qualities. While
the analysis of the psychometric properties in this review do indicate that this technology can
accurately and reliably measure limb volume, there are still limitations to clinical adoption of 3D
scanning.
The multi-camera systems demonstrate both high reliability and excellent validity, but
these systems require space and time to use. Some systems can quickly scan a limb, but the
processing of the scan is dependent on operator manipulation, which takes additional time. To
use the Vectra 3D Scanner, each side of the limb is scanned (medial and lateral) separately, and
then stitched together.[22, 23] This step can introduce errors in accuracy, especially in a busy
clinic. The scanner described by Hameeteman, et al,[21] scans the upper part of a limb and the
lower part of a limb separately, and then the images are combined. This process also introduces
human error. The stationary systems investigated in this study include the Perometer, which
remains expensive, and with a lack of true portability, inefficient for clinical use. The other 3D
scanner used has limitations in portability as it requires a fixed plexiglass panel for reflectors that
are used for spatial reference.
The portable scanners show the greatest promise for clinical adoption, but the technology
presented in the reviewed studies is quickly out-dated. Two of the studies used an older model
of the Microsoft Kinect sensor which is no longer commercially available. While a newer
version has since been released, this is not yet adapted to a clinical purpose. Even with such a
scanner, the image was processed by software (Skanect 3D Scanning Software, Occipital, San
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Francisco, CA) that required end-user processing. The single study in the portable scanner
category that uses a currently available scanner (Structure Sensor, Occipital, San Francisco, CA)
in a convenient manner also includes software specifically designed to measure limb volume
(Lymphatech, Atlanta, GA).[30] This technology appears to be the most promising to develop
into a commercially available device that is validated prospectively in a population of individuals
with lymphedema.
The intent of the investigation was to determine if there are valid, reliable, and
feasible methods to measure limb volume with the goal of using this technology within a
population with lymphedema. As 3D imaging is an emerging technology in the medical
community, current research is limited to reliability and validity, often in a healthy
population. Often initial studies examining the psychometric properties of measurement
tools begin with healthy populations, however, it is essential that additional research on
those with lymphedema take place, especially to evaluate the diagnostic accuracy and
responsiveness of the tool.
While all of these methods appear to have good reliability and validity, the concern that
there is no universal method to diagnose BCRL remains. This issue may lead to varying
measurements or undiagnosed lymphedema. In addition to having valid and reliable
measurement tools to measure limb volume, a universally accepted diagnostic criteria is needed.
Further research and expert consensus is needed to identify diagnostic cut points for
lymphedema.
Limitations
This systematic review has several limitations that make the findings difficult to use to
effect clinical change of practice for limb volume measurement. First, the search took place in
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March 2019. It is possible that more current studies have since been published. Secondly, while
the Perometer is often accepted as a reference standard for other limb volume measures, many of
the original Perometer validation studies used CM as the reference standard. As CM is known to
overestimate limb volume, the findings of this review could not be compared to these other
studies. This ultimately limited the number of studies included in the final analysis. Since none
of the methods of 3D scanning included a full range of psychometric studies, no one method
emerges as the best method to adopt clinically.
It is clear that technology is rapidly advancing, and that 3D imaging holds the promise of
efficient and accurate scanning to measure limb volume. Further research must investigate both
the scanners and the software to rigorously test the psychometrics of these systems. This, along
with an objective consensus on what constitutes lymphedema, is essential to address the unmet
need to identify those at risk for and with early lymphedema to prevent the development of
irreversible lymphedema.
Conclusion
The purpose of this systematic review was to investigate the psychometric properties of
3D imaging to measure limb volume, with the intent of determining whether this newer
technology might address the flaws present with water displacement and circumferential tape
measure limb volume measurement. The significant results of this review help to show that
using newer methods of measurement are accurate to measure limb volume. Future research
in those with breast cancer-related lymphedema is necessary to evaluate diagnostic
accuracy and responsiveness before adoption of this method of measurement can take
place. The limitations to both water displacement and circumferential measurements can be
addressed by using a portable 3D scanner.
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